HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Greater occipital nerve blocks in chronic cluster headache: a prospective open-label study.

AbstractBACKGROUND AND PURPOSE:
Greater occipital nerve blockade (GONB) has been shown to be effective in episodic cluster headache. However, its use in chronic cluster headache (CCH) is less certain. The study aims to prospectively assess the efficacy and consistency of response to GONB in a large series of CCH patients.
METHODS:
CCH patients who had a unilateral GONB and were referred to the National Hospital for Neurology and Neurosurgery were studied prospectively. Headache characteristics were collected using headache diaries. Responders were considered to be patients with a complete or partial response lasting at least 7 days. In a subgroup of responders the outcomes of serial GONB performed at 3-monthly intervals were also analysed.
RESULTS:
Eighty-three CCH patients were studied. After the first GONB, a positive response was observed in 47 (57%) patients: 35 (42%) were rendered pain free, 12 (15%) had a partial benefit and one patient obtained <50% improvement. The duration of a positive response lasted a median of 21 days (range 7-504 days). There was a transient worsening of condition in 6% of patients. The overall rate and average duration of response remained consistent after the second [n = 37; 31 responders (84%); median duration 21 days], third [n = 28; 20 responders (71%); median duration 25 days] and fourth [n = 14; 10 responders (71%); median duration 23 days] injections.
CONCLUSION:
GONB seems to be an efficacious treatment with reproducible effects in CCH patients. Performed three monthly, GONB may have a useful role in the management of CCH.
AuthorsG Lambru, N Abu Bakar, L Stahlhut, S McCulloch, S Miller, P Shanahan, M S Matharu
JournalEuropean journal of neurology (Eur J Neurol) Vol. 21 Issue 2 Pg. 338-43 (Feb 2014) ISSN: 1468-1331 [Electronic] England
PMID24313966 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Copyright© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.
Chemical References
  • Analgesics
  • Lidocaine
  • Methylprednisolone
Topics
  • Adult
  • Aged
  • Analgesics (therapeutic use)
  • Cluster Headache (drug therapy)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lidocaine (therapeutic use)
  • Male
  • Methylprednisolone (therapeutic use)
  • Middle Aged
  • Nerve Block (methods)
  • Prospective Studies
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: